» Articles » PMID: 36245711

High Detection Rate for Disease-causing Variants in a Cohort of 30 Iranian Pediatric Steroid Resistant Nephrotic Syndrome Cases

Abstract

Background: Steroid resistant nephrotic syndrome (SRNS) represents a significant renal disease burden in childhood and adolescence. In contrast to steroid sensitive nephrotic syndrome (SSNS), renal outcomes are significantly poorer in SRNS. Over the past decade, extensive genetic heterogeneity has become evident while disease-causing variants are still only identified in 30% of cases in previously reported studies with proportion and type of variants identified differing depending on the age of onset and ethnical background of probands. A genetic diagnosis however can have implications regarding clinical management, including kidney transplantation, extrarenal disease manifestations, and, in some cases, even causal therapy. Genetic diagnostics therefore play an important role for the clinical care of SRNS affected individuals.

Methodology And Results: Here, we performed Sanger sequencing and subsequent exome sequencing in 30 consanguineous Iranian families with a child affected by SRNS with a mean age of onset of 16 months. We identified disease-causing variants and one variant of uncertain significance in 22 families (73%), including variants in (30%), followed by (20%), (%) as well as in , and in single cases. Eight of these variants have not previously been reported as disease-causing, including four variants and one variant in , and each.

Conclusion: In line with previous studies in non-Iranian subjects, we most frequently identified disease-causing variants in and . While Sanger sequencing of can be considered as first diagnostic step in non-congenital cases, the genetic heterogeneity underlying SRNS renders next-generation sequencing based diagnostics as the most efficient genetic screening method. In accordance with the mainly autosomal recessive inheritance pattern, diagnostic yield can be significantly higher in consanguineous than in outbred populations.

Citing Articles

Clinical presentation and management challenges of sphingosine-1-phosphate lyase insufficiency syndrome associated with an SGPL1 variant: a case report.

Saeedi V, Rahimzadeh N, Ehsanipour F, Shalbaf N, Farahi A, Rashidi K BMC Pediatr. 2025; 25(1):1.

PMID: 39755650 PMC: 11699824. DOI: 10.1186/s12887-024-05311-y.


Prevalence estimate of sphingosine phosphate lyase insufficiency syndrome in worldwide and select populations.

Sedillo J, Badduke C, Schrodi S, Scaria V, Onat O, Alfadhel M Genet Med Open. 2024; 2:100840.

PMID: 39669624 PMC: 11613930. DOI: 10.1016/j.gimo.2023.100840.


NPHS Mutations in Pediatric Patients with Congenital and Steroid-Resistant Nephrotic Syndrome.

Lee J, Tan Y, Ismail N Int J Mol Sci. 2024; 25(22).

PMID: 39596340 PMC: 11594456. DOI: 10.3390/ijms252212275.


Factors influencing survival in sphingosine phosphate lyase insufficiency syndrome: a retrospective cross-sectional natural history study of 76 patients.

Keller N, Midgley J, Khalid E, Lesmana H, Mathew G, Mincham C Orphanet J Rare Dis. 2024; 19(1):355.

PMID: 39334450 PMC: 11429486. DOI: 10.1186/s13023-024-03311-w.


Nucleoporin-associated steroid-resistant nephrotic syndrome.

Yao L, Li Y, Wang P, Xu C, Yu Z Pediatr Nephrol. 2024; 40(3):629-649.

PMID: 39331077 DOI: 10.1007/s00467-024-06494-3.


References
1.
Chernin G, Heeringa S, Gbadegesin R, Liu J, Hinkes B, Vlangos C . Low prevalence of NPHS2 mutations in African American children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2008; 23(9):1455-60. PMC: 5495478. DOI: 10.1007/s00467-008-0861-7. View

2.
Lipska-Zietkiewicz B, Ozaltin F, Holtta T, Bockenhauer D, Berody S, Levtchenko E . Genetic aspects of congenital nephrotic syndrome: a consensus statement from the ERKNet-ESPN inherited glomerulopathy working group. Eur J Hum Genet. 2020; 28(10):1368-1378. PMC: 7608398. DOI: 10.1038/s41431-020-0642-8. View

3.
Park E, Lee C, Kim N, Ahn Y, Park Y, Lee J . Genetic Study in Korean Pediatric Patients with Steroid-Resistant Nephrotic Syndrome or Focal Segmental Glomerulosclerosis. J Clin Med. 2020; 9(6). PMC: 7355646. DOI: 10.3390/jcm9062013. View

4.
Rheault M, Gbadegesin R . The Genetics of Nephrotic Syndrome. J Pediatr Genet. 2016; 5(1):15-24. PMC: 4918703. DOI: 10.1055/s-0035-1557109. View

5.
Najafi M, Kordi-Tamandani D, Behjati F, Sadeghi-Bojd S, Bakey Z, Karimiani E . Mimicry and well known genetic friends: molecular diagnosis in an Iranian cohort of suspected Bartter syndrome and proposition of an algorithm for clinical differential diagnosis. Orphanet J Rare Dis. 2019; 14(1):41. PMC: 6375149. DOI: 10.1186/s13023-018-0981-5. View